Developing minimally invasive, tools and technologies for high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders

Project Information

SCHIZDX

Grant agreement ID: 223427

Project closed

Start date 1 October 2008

End date 31 March 2012

Funded under

• Specific Programme "Cooperation": Health

Total cost € 3 586 932,20

EU contribution € 2 757 688,00

Coordinated by

Psynova Neurotech Ltd
United Kingdom